AptarGroup Inc., a global leader in drug and consumer product dosing, dispensing, and protection technologies, recently presented at William Blair's 45th Annual Growth Stock Conference. The presentation highlighted Aptar's significant global presence, with over 13,000 employees across 20 countries and a customer base of more than 5,000 global clients. In 2024, Aptar reported annual revenue of $3.6 billion, with the Pharma segment contributing 46% of total sales and 67% of adjusted EBITDA. The company emphasized its strong innovation pipeline, boasting over 7,000 active and pending patents. Aptar is recognized as a sustainability leader, leveraging its proprietary drug delivery systems and eco-design tools to maintain a competitive edge. The presentation underscored Aptar's commitment to leveraging its robust balance sheet for growth opportunities within a target leverage corridor of 1-3x. You can access the full presentation through the link below.